Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan vs Lansoprazole in Duodenal Ulcer
NCT05010954Phase 3Completed
- Sponsor
- Shandong Luoxin Pharmaceutical
- Start
- Oct 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegoprazan in duodenal ulcer, sponsored by Shandong Luoxin Pharmaceutical. Started Oct 2021; status: completed.
02
Drugs
tegoprazan
03
Conditions
duodenal ulcer
Beyond the preview
Go deeper on NCT05010954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05010954.